Company intelligence / Profile preview

Biomedix

United States

Ownership: Private
Development stage: Other

Overview

Biomedix provides front-line diagnostic devices and platforms, including PADnet, a market-leading system for the detection of peripheral artery disease and chronic venous insufficiency. The company’s solutions have demonstrated impact in improving early diagnosis and enabling collaborative care models for value-based healthcare, particularly in remote and point-of-care settings[2][3][4].

Therapeutic areas: Cardiovascular
Modalities: DeviceDiagnostic
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Biomedix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomedix.

Explore the full profile